# An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

> **NCT06655519** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Relapsed/Refractory Multiple Myeloma
- Plasma Cell Leukemia

## Interventions

- **BIOLOGICAL:** CAR-T（RD140 injection）

## Key facts

- **NCT ID:** NCT06655519
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2028-07-05
- **Final completion:** 2041-07-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655519, "An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06655519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*